4.2 Review

Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy

Related references

Note: Only part of the references are listed.
Review Oncology

Prime time for immune-checkpoint targeted therapy at ASCO 2015

Aurelien Marabelle et al.

ONCOIMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

Nicholas McGranahan et al.

SCIENCE (2016)

Review Oncology

Novel technologies and emerging biomarkers for personalized cancer immunotherapy

Jianda Yuan et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)

Review Oncology

Epigenetic treatment of solid tumours: a review of clinical trials

Clara Nervi et al.

CLINICAL EPIGENETICS (2015)

Article Multidisciplinary Sciences

Mining CK2 in Cancer

Charina E. Ortega et al.

PLOS ONE (2014)

Article Multidisciplinary Sciences

Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice

Biljana Ljujic et al.

SCIENTIFIC REPORTS (2013)

News Item Pharmacology & Pharmacy

Comprehensive care and care at the center of the new recommendation HAS

Elisa Derrien

ACTUALITES PHARMACEUTIQUES (2012)

Review Oncology

Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links

Christina Scheel et al.

SEMINARS IN CANCER BIOLOGY (2012)

Article Cell & Tissue Engineering

Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells

Kristel Kemper et al.

STEM CELLS (2012)

Article Multidisciplinary Sciences

Interactions between cancer stem cells and their niche govern metastatic colonization

Ilaria Malanchi et al.

NATURE (2012)

Article Oncology

CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma

Matthew A. Price et al.

PIGMENT CELL & MELANOMA RESEARCH (2011)

Review Biochemistry & Molecular Biology

Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer

Anna L. Stratford et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)

Article Oncology

CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer

Xinhui Wang et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Article Biotechnology & Applied Microbiology

Antitumor Immunity and Cancer Stem Cells

Tobias Schatton et al.

HEMATOPOIETIC STEM CELLS VII (2009)

Review Biochemistry & Molecular Biology

The Tortoise and the Hair: Slow-Cycling Cells in the Stem Cell Race

Elaine Fuchs

Article Cell & Tissue Engineering

DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency

Timothy Hoey et al.

CELL STEM CELL (2009)

Review Medicine, Research & Experimental

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease

Herve Acloque et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Review Oncology

Crucial role of interleukin-4 in the survival of colon cancer stem cells

Maria Giovanna Francipane et al.

CANCER RESEARCH (2008)

Article Cell & Tissue Engineering

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Christophe Ginestier et al.

CELL STEM CELL (2007)

Article Biochemistry & Molecular Biology

Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma

Gentao Liu et al.

MOLECULAR CANCER (2006)

Review Oncology

Cancer stem cells: An old idea - A paradigm shift

MS Wicha et al.

CANCER RESEARCH (2006)